Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:38:57 EST Sat 17 Jan 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:GCTK - GLUCOTRACK INC - https://glucotrack.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
GCTK - Q0.13.48·6.000.93.96-0.02-0.526.4961943.99  4.075  3.7501169.1997  3.2116:29:42Dec 3015 min RT 2¢

Recent Trades - Last 10 of 194
Time ETExPriceChangeVolume
16:29:42Q3.89-0.091
16:04:27Q3.96-0.021
16:04:22Q3.96-0.021
16:04:20Q3.96-0.021
16:04:18Q3.96-0.021
16:00:00Q3.96-0.022
16:00:00Q3.96-0.022
16:00:00Q3.96-0.022
16:00:00Q3.96-0.022
16:00:00Q3.96-0.022

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-12-30 08:00U:GCTKNews ReleaseGlucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
2025-11-13 16:05U:GCTKNews ReleaseGlucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights
2025-11-03 16:05U:GCTKNews ReleaseGlucotrack, Inc. Encourages Shareholders to Vote
2025-10-29 16:05U:GCTKNews ReleaseGlucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team
2025-10-28 08:00U:GCTKNews ReleaseGlucotrack, Inc. Reminds Shareholders to Vote
2025-09-11 08:00U:GCTKNews ReleaseGlucotrack to Participate in the Q3 Virtual Investor Summit
2025-08-14 16:05U:GCTKNews ReleaseGlucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
2025-08-06 08:30U:GCTKNews ReleaseGlucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology
2025-07-31 08:30U:GCTKNews ReleaseGlucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting
2025-07-08 08:30U:GCTKNews ReleaseGlucotrack Announces Repurchase of Series A Warrants
2025-06-25 08:30U:GCTKNews ReleaseGlucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions
2025-06-12 09:05U:GCTKNews ReleaseGlucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements
2025-06-04 08:30U:GCTKNews ReleaseGlucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions
2025-05-28 08:30U:GCTKNews ReleaseGlucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
2025-05-20 08:30U:GCTKNews ReleaseGlucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development
2025-05-14 17:10U:GCTKNews ReleaseGlucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
2025-05-13 08:01U:GCTKNews ReleaseGlucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor
2025-04-16 08:00U:GCTKNews ReleaseGlucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas
2025-04-03 08:01U:GCTKNews ReleaseGlucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor
2025-03-31 17:00U:GCTKNews ReleaseGlucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights